United States Cardiovascular Surgery Market Outlook to 2020

Summary

GlobalData’s new report, "United States Cardiovascular Surgery Market Outlook to 2020", provides key market data on the United States Cardiovascular Surgery Market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Beating Heart Surgery Systems, Cardiac Ablation Devices, Cardiopulmonary Bypass Equipment and Perfusion Disposables.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Cardiovascular Surgery Market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Cardiovascular Surgery Devices categories - Beating Heart Surgery Systems, Cardiac Ablation Devices, Cardiopulmonary Bypass Equipment and Perfusion Disposables
- Annualized market revenue (USD million), volume (units) and average selling price ($) data for the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
- 2012 company shares and distribution shares data for the market category.
- Global corporate-level profiles of key companies operating within the United States Cardiovascular Surgery Market.
- Key players covered include Medtronic, Inc., MAQUET GmbH & Co. KG, Sorin Group and Terumo Corporation.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

1 Table of Contents

2 Introduction 9
2.1 What Is This Report About? 9
2.2 Cardiovascular Surgery Market Segmentation 9
2.3 Definitions of Markets Covered in the Report 10
3 Cardiovascular Surgery Market, United States 12
3.1 Cardiovascular Surgery Market, United States, Revenue ($m), 2005-2012 12
3.2 Cardiovascular Surgery Market, United States, Revenue ($m), 2012-2020 14
3.2.1 Beating Heart Surgery Systems Market, United States, Revenue ($m), by Segment, 2005-2012 16
3.2.2 Perfusion Disposables Market, United States, Revenue ($m), by Segment, 2005-2012 18
3.2.3 Beating Heart Surgery Systems Market, United States, Revenue ($m), by Segment, 2012-2020 20
3.2.4 Perfusion Disposables Market, United States, Revenue ($m), by Segment, 2012-2020 22
3.3 Cardiovascular Surgery Market, United States, Volume (Units), 2005-2012 24
3.4 Cardiovascular Surgery Market, United States, Volume (Units), 2012-2020 26
3.4.1 Beating Heart Surgery Systems Market, United States, Volume (Units), by Segment, 2005-2012 28
3.4.2 Perfusion Disposables Market, United States, Volume (Units), by Segment, 2005-2012 30
3.4.3 Beating Heart Surgery Systems Market, United States, Volume (Units), by Segment, 2012-2020 32
3.4.4 Perfusion Disposables Market, United States, Volume (Units), by Segment, 2012-2020 34
3.5 Cardiovascular Surgery Market, United States, Average Price ($), 2005-2020 36
3.6 Cardiovascular Surgery Market, United States, Distribution Share by Revenue ($m), 2011-2012 38
3.7 Cardiovascular Surgery Market, United States, Company Share by Revenue ($m), 2011-2012 39
4 Overview of Key Companies in United States, Cardiovascular Surgery Market 41
4.1 Medtronic, Inc. 41
4.1.1 Company Overview 41
4.2 Maquet Holding B.V. and Co. KG. 41
4.2.1 Company Overview 41
4.3 Sorin S.p.A. 41
4.3.1 Company Overview 41
4.4 Terumo Corporation 42
4.4.1 Company Overview 42
5 Cardiovascular Surgery Market Pipeline Products 43
6 Financial Deals Landscape 44
6.1 Acquisition 44
6.1.1 Sorin Acquires California Medical Labs, Maker Of Cardiovascular Cannulae, For US$14 Million 44
6.2 Debt Offerings 46
6.2.1 Medtronic Completes Public Offering Of Notes Due 2017 For US$250 Million 46
6.2.2 Medtronic Completes Public Offering Of 0.875% Notes Due 2017 For US$250 Million 48
6.2.3 Medtronic Completes Public Offering Of Notes Due 2024 For US$850 Million 50
6.2.4 Medtronic Completes Public Offering Of Notes Due 2044 For US$650 Million 52
6.2.5 Medtronic Completes Public Offering Of Notes Due 2018 For US$1 Billion 54
6.2.6 Medtronic Completes Public Offering Of Notes Due 2043 For US$750 Million 56
6.2.7 Medtronic Completes Public Offering Of Notes Due 2023 For US$1.25 Billion 58
6.3 Equity Offerings 60
6.3.1 Cardica Prices Public Offering Of Preferred Stock For US$16.3 Million 60
6.3.2 Cardica Completes Public Offering Of Shares For US$31.8 Million 62
6.3.3 Cardica Completes Public Offering Of Shares For US$15 Million 64
6.4 Partnerships 65
6.4.1 Sun Biomedical Plans To Enter Into Licensing Agreement With Parvulus Suisse 65
6.4.2 Xenios Enters Into Licensing Agreement With Leukocare For Next Generation Extracorporeal Support Systems 66
6.4.3 Minnetronix Enters Into Licensing Agreement With Penn State Research Foundation For Wireless Energy Transmission Technology 67
6.5 Venture Financing 68
6.5.1 Tenaxis Medical Raises US$1.4 Million In Venture Financing 68
6.5.2 Medrobotics Raises US$21.3 Million In Venture Financing 69
6.5.3 BioVentrix Raises US$0.5 Million In Venture Financing 70
6.5.4 CHF Technologies Raises US$0.8 Million In Venture Financing 71
7 Recent Developments 72
7.1 Corporate Communications 72
7.1.1 Feb 18, 2014: SurModics Announces Changes to Board of Directors 72
7.1.2 Jan 13, 2014: Cardica Appoints Industry Veteran Liam Burns As Vice President, Sales And Marketing 73
7.1.3 Dec 04, 2013: Cook Medical Names Rob Lyles Executive Vice President 73
7.1.4 Dec 04, 2013: Mark Breedlove Named Vice President of Cook Medical’s Peripheral Intervention Clinical Division 73
7.1.5 Oct 01, 2013: Gretchen Gutman Named Vice President of Public Policy for Cook Group 74
7.1.6 Sep 23, 2013: BioVentrix Appoints Cardiology Expert Dr. Serjan Nikolic as Vice President of Therapy Development 74
7.1.7 Sep 20, 2013: SurModics Announces Board Changes 75
7.1.8 Aug 22, 2013: Nicky James Named Vice President and Global Leader of Cook Medical Aortic Intervention Clinical Division 76
7.1.9 Jul 09, 2013: CryoLife Enhances International Presence with Appointment of Andres Sarmiento as Latin America Sales Manager 76
7.2 Financial Announcements 77
7.2.1 May 01, 2014: Cardica Announces Fiscal 2014 Third Quarter Financial Results 77
7.2.2 May 01, 2014: SurModics Reports Second Quarter Fiscal 2014 Results 78
7.2.3 Apr 24, 2014: Merit Medical Reports Sales Up 15% for the Quarter Ended March 31, 2014 80
7.2.4 Feb 24, 2014: Merit Medical Reports Record Revenues for the Quarter and Year Ended December 31, 2013 81
7.2.5 Feb 20, 2014: CryoLife Fourth Quarter 2013 Revenues Increased 8 Percent to a Record $35.5 Million 83
7.2.6 Feb 18, 2014: Medtronic Reports Third Quarter Earnings 85
7.2.7 Feb 04, 2014: Cardica Announces Fiscal 2014 Second Quarter Financial Results 87
7.2.8 Jan 30, 2014: SurModics Reports First Quarter Fiscal 2014 Results 88
7.2.9 Nov 19, 2013: Medtronic Reports Second Quarter Earnings 89
7.2.10 Nov 11, 2013: Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2014 91
7.2.11 Nov 05, 2013: SurModics Reports Fourth Quarter and Full Year 2013 Results 91
7.2.12 Nov 04, 2013: Cardica Announces Fiscal 2014 First Quarter Financial Results 93
7.2.13 Oct 29, 2013: CryoLife Third Quarter 2013 Revenues Increase 8 Percent to a Record $36.3 Million 95
7.2.14 Oct 29, 2013: SurModics to Webcast Fourth Quarter and Fiscal Year 2013 Earnings Conference Call on November 5 97
7.2.15 Oct 23, 2013: Merit Medical Announces Results for the Quarter Ended September 30, 2013 97
7.2.16 Oct 21, 2013: Cardica To Announce Fiscal 2014 First Quarter Financial Results On Monday, November 4, 2013 99
7.2.17 Oct 14, 2013: CryoLife Announces Release Date and Teleconference Call Details for 2013 Third Quarter Financial Results 99
7.2.18 Oct 07, 2013: Merit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the Third Quarter Ended September 30, 2013 99
7.2.19 Aug 20, 2013: Medtronic Reports First Quarter Earnings 99
7.2.20 Aug 12, 2013: Medtronic to Announce Financial Results for Its First Quarter of Fiscal Year 2014 101
7.2.21 Aug 05, 2013: Cardica Announces Fiscal 2013 Fourth Quarter And Full Year Financial Results 101
7.2.22 Jul 31, 2013: SurModics Reports Third Quarter Fiscal 2013 Results 103
7.2.23 Jul 31, 2013: Merit Medical Reports Record Revenues, up Nine Percent, for the Quarter and Six Months Ended June 30, 2013 104
7.2.24 Jul 25, 2013: CryoLife Reports Record Second Quarter Revenues 106
7.2.25 Jul 23, 2013: SurModics to Webcast Third Quarter 2013 Earnings Conference Call on July 31 108
7.2.26 Jul 22, 2013: Cardica to Announce Fiscal 2013 Fourth Quarter and Full Year Financial Results On Monday, August 5, 2013 108
7.2.27 Jul 11, 2013: CryoLife Announces Release Date and Teleconference Call Details for 2013 Second Quarter Financial Results 109
7.2.28 Jul 11, 2013: CryoLife Announces Release Date and Teleconference Call Details for 2013 Second Quarter Financial Results 109
7.2.29 Jul 08, 2013: Merit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the Second Quarter Ended June 30, 2013 109
7.2.30 May 21, 2013: Medtronic Reports Revenue Of $16.6 Billion In Fiscal 2013 110
7.2.31 May 07, 2013: SurModics Reports Second Quarter Fiscal 2013 Results 111
7.3 Government and Public Interest 113
7.3.1 Jan 06, 2014: Medtronic CEO Omar Ishrak to Speak at J.P. Morgan Healthcare Conference 113
7.3.2 Dec 04, 2013: SurModics to Present at Oppenheimer Healthcare Conference 113
7.3.3 Dec 04, 2013: Medtronic CFO Gary Ellis to Speak at Oppenheimer Healthcare Conference 113
7.3.4 Nov 26, 2013: SurModics to Present at Piper Jaffray Healthcare Conference 113
7.3.5 Nov 26, 2013: Medtronic EVP and President Mike Coyle to Speak at Piper Jaffray Healthcare Conference 114
7.3.6 Nov 26, 2013: Merit Medical to Participate at Piper Jaffray Healthcare Conference 114
7.3.7 Nov 25, 2013: CryoLife to Present at 25th Annual Piper Jaffray Healthcare Conference 114
7.3.8 Nov 12, 2013: Merit Medical to Present at Stephens and Canaccord Genuity Conferences This Week 114
7.3.9 Nov 12, 2013: SurModics to Present at Canaccord Genuity Medical Technology and Diagnostics Conference 115
7.3.10 Sep 11, 2013: Cardica To Present At Craig-Hallum Alpha Select Conference 115
7.3.11 Sep 06, 2013: Medtronic CFO Gary Ellis to Speak at Morgan Stanley Healthcare Conference 115
7.3.12 Sep 03, 2013: Merit Medical to Present at CL King Conference 115
7.3.13 Aug 27, 2013: SurModics to Present at CL King’s Best Ideas Conference 115
7.3.14 Aug 07, 2013: Cardica to Present at Wedbush 2013 Life Sciences Management Access Conference 116
7.3.15 Aug 01, 2013: Merit Medical to Participate at Canaccord Genuity Growth Conference 116
7.3.16 May 21, 2013: SurModics to Present at the Jefferies Global Healthcare Conference 116
7.4 Legal And Regulatory 116
7.4.1 Apr 11, 2014: Federal Court Orders Preliminary Injunction on U.S. Sales of Medtronic's Infringing Transcatheter Valve 116
7.4.2 Mar 12, 2014: Venaxis to Discuss Top-Line Results from Pivotal Study of APPY1 Test 117
7.4.3 Jan 22, 2014: Medtronic Statement on U.S. Supreme Court Ruling in Medtronic, Inc. v. Mirowski Family Ventures 117
7.4.4 Oct 19, 2013: Medtronic Statement on Medical Device Security 118
7.4.5 Aug 01, 2013: Medtronic Notifies More Than 2,700 Patients Of Lost Records 118
7.4.6 Jul 01, 2013: Bronstein, Gewirtz and Grossman, LLC Announces that a Securities Class Action has been Filed Against Medtronic, Inc. 119
7.4.7 May 29, 2013: Edwards Lifesciences Gets FDA Warning Letter Regarding Cardiac Surgery Systems 119
7.5 Other Significant Developments 120
7.5.1 Feb 24, 2014: Cesca Therapeutics and Cook Medical Enter Supply Agreement for a Phase 1b Clinical Trial 120
7.5.2 Feb 19, 2014: CryoLife Announces Quarterly Cash Dividend for the First Quarter 2014 120
7.5.3 Feb 13, 2014: Medtronic Announces Cash Dividend for Fourth Quarter of Fiscal Year 2014 120
7.5.4 Jan 28, 2014: Medtronic Relocates Its Regional Headquarters to Dubai 121
7.5.5 Jan 27, 2014: Saint Luke's awarded $3.4 million grant from Boston Scientific for further research into innovative cardiac procedures 122
7.5.6 Dec 16, 2013: Genzyme and NORD Establish Program to Help Undiagnosed Patients with Rare Diseases 123
7.5.7 Dec 04, 2013: Medtronic Issues $500,000 in Health Access Grants to Support Diabetes Services for the Underserved of Greater Los Angeles 123
7.5.8 Nov 21, 2013: CryoLife Announces Quarterly Cash Dividend for the Fourth Quarter 2013 125
7.5.9 Sep 03, 2013: SurModics Announces Organizational Changes 125
7.5.10 Aug 22, 2013: Medtronic Announces Cash Dividend for Second Quarter of Fiscal Year 2014 126
7.5.11 Aug 21, 2013: CryoLife Announces Quarterly Cash Dividend for the Third Quarter 2013 126
7.5.12 Jul 22, 2013: SurModics to Present at the InvestMNt Conference 126
7.5.13 Jul 12, 2013: Hospitals, Healthcare Providers to Benefit from a New Premier Agreement for Vascular Closure Devices 126
7.6 Product News 127
7.6.1 Nov 18, 2013: New Study May Impact Practice Guidelines for Mitral Valve Surgery for Severe Ischemic Mitral Regurgitation 127
7.6.2 Nov 18, 2013: LVAD Patients Benefit from Heart Injection with Millions of Powerful Cells 128
7.6.3 Nov 15, 2013: FDA Classifies Medtronic's Worldwide Voluntary Field Action on Guidewires as Class I Recall 129
7.6.4 Nov 14, 2013: Endovascular Aneurysm Training Module Now Supports Vascutek's Anaconda Devices 129
7.7 Research And Development 130
7.7.1 May 30, 2013: Cook Medical Joins With Indiana Life Science Businesses, Academia And Government To Help Launch Bioscience Research Center 130
7.8 Strategy And Business Planning 131
7.8.1 Mar 15, 2014: Merit Medical Opens Office in Bangalore, India 131
7.8.2 Feb 04, 2014: Purdue Research Foundation, Cook Medical partner on $12 million project to support life sciences startup opportunities 131
7.8.3 Nov 14, 2013: Cook Medical Opens New Innovation Centre in Limerick, Ireland 132
7.8.4 Sep 17, 2013: Medtronic Opens New Customer Innovation Centre in Galway, Ireland 133
7.8.5 Sep 02, 2013: Medtronic announces formation of hospital solutions business aimed at driving efficiencies 133
7.8.6 Aug 29, 2013: Medtronic To Set Up Global Center Of Excellence In Singapore For Business Model Innovation 135
8 Appendix 136
8.1 Research Methodology 137
8.1.1 Coverage 137
8.1.2 Secondary Research 137
8.1.3 Primary Research 138
8.1.4 Market Modeling and Forecasting 139
8.1.5 Company Share Analysis 142
8.1.6 Distribution Share Analysis 143
8.2 Expert Panel 143
8.3 GlobalData Consulting 144
8.4 Contact Us 144
8.5 Disclaimer 144

1.1 List of Tables
Table 1: Cardiovascular Surgery Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 13
Table 2: Cardiovascular Surgery Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 15
Table 3: Beating Heart Surgery Systems Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 17
Table 4: Perfusion Disposables Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 19
Table 5: Beating Heart Surgery Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 21
Table 6: Perfusion Disposables Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 23
Table 7: Cardiovascular Surgery Market, United States, Volume (Units), Historic, 2005-2012 25
Table 8: Cardiovascular Surgery Market, United States, Volume (Units), Forecast, 2012-2020 27
Table 9: Beating Heart Surgery Systems Market, United States, Volume (Units), Historic, 2005-2012 29
Table 10: Perfusion Disposables Market, United States, Volume (Units), Historic, 2005-2012 31
Table 11: Beating Heart Surgery Systems Market, United States, Volume (Units), Forecast, 2012-2020 33
Table 12: Perfusion Disposables Market, United States, Volume (Units), Forecast, 2012-2020 35
Table 13: Cardiovascular Surgery Market, United States, Average Price ($), Historic, 2005-2012 36
Table 14: Cardiovascular Surgery Market, United States, Average Price ($), Forecast, 2012-2020 37
Table 15: Cardiovascular Surgery Market, United States, Distribution Share by Revenue ($m), USD Constant, 2011-2012 38
Table 16: Cardiovascular Surgery Market, United States, Company Share by Revenue ($m), USD Constant, 2011-2012 40
Table 17: Cardiovascular Surgery Market Pipeline Products 43
Table 18: Sorin Acquires California Medical Labs, Maker Of Cardiovascular Cannulae, For US$14 Million 44
Table 19: Medtronic Completes Public Offering Of Notes Due 2017 For US$250 Million 46
Table 20: Medtronic Completes Public Offering Of 0.875% Notes Due 2017 For US$250 Million 48
Table 21: Medtronic Completes Public Offering Of Notes Due 2024 For US$850 Million 50
Table 22: Medtronic Completes Public Offering Of Notes Due 2044 For US$650 Million 52
Table 23: Medtronic Completes Public Offering Of Notes Due 2018 For US$1 Billion 54
Table 24: Medtronic Completes Public Offering Of Notes Due 2043 For US$750 Million 56
Table 25: Medtronic Completes Public Offering Of Notes Due 2023 For US$1.25 Billion 58
Table 26: Cardica Prices Public Offering Of Preferred Stock For US$16.3 Million 60
Table 27: Cardica Completes Public Offering Of Shares For US$31.8 Million 62
Table 28: Cardica Completes Public Offering Of Shares For US$15 Million 64
Table 29: Sun Biomedical Plans To Enter Into Licensing Agreement With Parvulus Suisse 65
Table 30: Xenios Enters Into Licensing Agreement With Leukocare For Next Generation Extracorporeal Support Systems 66
Table 31: Minnetronix Enters Into Licensing Agreement With Penn State Research Foundation For Wireless Energy Transmission Technology 67
Table 32: Tenaxis Medical Raises US$1.4 Million In Venture Financing 68
Table 33: Medrobotics Raises US$21.3 Million In Venture Financing 69
Table 34: BioVentrix Raises US$0.5 Million In Venture Financing 70
Table 35: CHF Technologies Raises US$0.8 Million In Venture Financing 71
Table 36: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country 139

1.2 List of Figures
Figure 1: Cardiovascular Surgery Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 12
Figure 2: Cardiovascular Surgery Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 14
Figure 3: Beating Heart Surgery Systems Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 16
Figure 4: Perfusion Disposables Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 18
Figure 5: Beating Heart Surgery Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 20
Figure 6: Perfusion Disposables Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 22
Figure 7: Cardiovascular Surgery Market, United States, Volume (Units), Historic, 2005-2012 24
Figure 8: Cardiovascular Surgery Market, United States, Volume (Units), Forecast, 2012-2020 26
Figure 9: Beating Heart Surgery Systems Market, United States, Volume (Units), Historic, 2005-2012 28
Figure 10: Perfusion Disposables Market, United States, Volume (Units), Historic, 2005-2012 30
Figure 11: Beating Heart Surgery Systems Market, United States, Volume (Units), Forecast, 2012-2020 32
Figure 12: Perfusion Disposables Market, United States, Volume (Units), Forecast, 2012-2020 34
Figure 13: Cardiovascular Surgery Market, United States, Company Share (%) 2012 39
Figure 14: GlobalData Epidemiology-Based Forecasting Model 141
Figure 15: GlobalData Capital Equipment-Based Forecasting Model 142
Figure 16: Primary Interviews by Participant Type (%) 143

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Emerging Trends in Neuromodulators (Technical Insights)

Emerging Trends in Neuromodulators (Technical Insights)

  • $ 6 500
  • Industry report
  • September 2014
  • by Frost & Sullivan

Exciting Technological and Business Vistas on the Horizon This research service showcases existing, emerging and cutting-edge Neuromodulation technologies. The report studies the role of Neuromodulation ...

Regenerative Medicine Market (Bone and Joint) (By Technology - By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products & Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013

Regenerative Medicine Market (Bone and Joint) (By Technology - By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products & Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013

  • $ 4 795
  • Industry report
  • July 2014
  • by Transparency Market Research

U.S. National Institute of Health stated that regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage, congenital ...

Regenerative Medicine Market (Bone and Joint) (By Technology - By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products...) - Global Industry Analysis, Size, Share, Growth, Trends & Forecast, 2013 - 2019

Regenerative Medicine Market (Bone and Joint) (By Technology - By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products...) - Global Industry Analysis, Size, Share, Growth, Trends & Forecast, 2013 - 2019

  • $ 4 795
  • Industry report
  • July 2014
  • by Transparency Market Research

U.S. National Institute of Health stated that regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage, congenital ...


1 Companies

Company Profiles

AstraZeneca PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.